相关实验视频

Updated: May 5, 2026

Promoter Capture Hi-C: High-resolution, Genome-wide Profiling of Promoter Interactions
10:16

Promoter Capture Hi-C: High-resolution, Genome-wide Profiling of Promoter Interactions

Published on: June 28, 2018

32.2K

与转录组结合的表观遗传特征揭示了KOCOSS-NIH中COPD和PRISM之间的差异

Eun-A Choi1, Hyun Jeong Kim2, Youlim Kim3

  • 1Division of Allergy and Respiratory Disease Research, Department of Chronic Disease Convergence Research, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Osong-Eup, Heungdeok-Gu, Cheongju, Republic of Korea.

Functional & integrative genomics
|April 9, 2025
PubMed
概括

保存比例受损螺旋计 (PRISm) 可能是慢性阻塞性肺病 (COPD) 的前身. 这项研究发现了PRISm和COPD之间的显著DNA甲基化差异,确定了区分这些疾病的七个关键基因区域.

关键词:
阿尔赫盖夫10 时间慢性慢性肺炎是一种慢性慢性肺炎,COPD是一种慢性肺炎.EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1EEF1EEF1EEF1EEF1EEF1EEF1EEF2EEF1EEF1EEF1EEF1EEF1EEF2EEF1EEF1EEF1EEF1EEF2EEF1EEF1EEF1EEF1EEF1EEF2EEF1EEF1EEF1EEF2EEF1EEF1EEF1EEF2EEF1EEF1E2EEF1E2EEF1E1E1E1E1E2E2E2E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1在EMP2中,我们可以使用EMP2.在EPCAM中,您可以使用EPCAM.这就是FADS2的原因.希丁尼 (HYDIN) 的意思是说,希丁尼.在MTSS1L中使用.这就是PRISM.

更多相关视频

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

5.2K
Author Spotlight: Development and Characterization of an In Vitro Model to Study Chronic Cigarette Smoke Exposure and Its Impact on Airway Epithelial Cells in COPD Research09:07

Author Spotlight: Development and Characterization of an In Vitro Model to Study Chronic Cigarette Smoke Exposure and Its Impact on Airway Epithelial Cells in COPD Research

Published on: July 12, 2024

896

相关概念视频

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.2K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
71
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
77